Global Cell and Gene Therapy CDMO Services Market Research Report 2026(Status and Outlook)
Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) services involve companies providing specialized expertise and infrastructure for the development, manufacturing, and commercialization of cell and gene therapy products on behalf of biopharmaceutical companies. These services encompass a range of activities, including process development, analytical testing, regulatory support, and manufacturing at various scales, from preclinical to commercial production. CDMOs play a critical role in accelerating the translation of cell and gene therapies from research to clinical application by offering tailored solutions to meet the unique requirements of each therapy, ultimately helping to bring innovative treatments to patients more efficiently and effectively.Due to complex technical mechanisms, high-threshold process development and large-scale production, strict regulatory requirements, and limited industrialization experience, CGT products are more dependent on CDMOs than traditional pharmaceuticals. Its outsourcing penetration rate exceeds 65%, far exceeding 35% of traditional biologics.Considering that the production of viral vectors as the core involves very complex processes, is extremely difficult, and has a long preparation cycle, it is expected that the outsourcing rate of CGT will remain high in the future.
The global Cell and Gene Therapy CDMO Services market size was estimated at USD 7715.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 32.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell and Gene Therapy CDMO Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell and Gene Therapy CDMO Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell and Gene Therapy CDMO Services market.
Global Cell and Gene Therapy CDMO Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Catalent
Lonza
Thermo Fisher
WuXi AppTec
Charles River
OxfordBioMedica
BrammerBio
CELLfor CURE
OBiO Technology
GenScript
Esco
Nikon
FUJIFILM
Pharmaron
Porton
Medicilon
JOINN Laboratories
Sofpromed
eXmoor
OmniaBio
RoslinCT
BioCentriq
PolTREG
Miltenyi Bioindustry
Market Segmentation (by Type)
Autologous Cell Therapy Products
Allogeneic Cell Therapy Products
Market Segmentation (by Application)
SMBs
Large Companies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell and Gene Therapy CDMO Services Market
Overview of the regional outlook of the Cell and Gene Therapy CDMO Services Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy CDMO Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell and Gene Therapy CDMO Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cell and Gene Therapy CDMO Services market size was estimated at USD 7715.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 32.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cell and Gene Therapy CDMO Services market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cell and Gene Therapy CDMO Services market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cell and Gene Therapy CDMO Services market.
Global Cell and Gene Therapy CDMO Services Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Catalent
Lonza
Thermo Fisher
WuXi AppTec
Charles River
OxfordBioMedica
BrammerBio
CELLfor CURE
OBiO Technology
GenScript
Esco
Nikon
FUJIFILM
Pharmaron
Porton
Medicilon
JOINN Laboratories
Sofpromed
eXmoor
OmniaBio
RoslinCT
BioCentriq
PolTREG
Miltenyi Bioindustry
Market Segmentation (by Type)
Autologous Cell Therapy Products
Allogeneic Cell Therapy Products
Market Segmentation (by Application)
SMBs
Large Companies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cell and Gene Therapy CDMO Services Market
Overview of the regional outlook of the Cell and Gene Therapy CDMO Services Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy CDMO Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cell and Gene Therapy CDMO Services, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy CDMO Services
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy CDMO Services Segment by Type
1.2.2 Cell and Gene Therapy CDMO Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL AND GENE THERAPY CDMO SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy CDMO Services Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell and Gene Therapy CDMO Services Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL AND GENE THERAPY CDMO SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell and Gene Therapy CDMO Services Product Life Cycle
3.3 Global Cell and Gene Therapy CDMO Services Sales by Manufacturers (2020-2025)
3.4 Global Cell and Gene Therapy CDMO Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell and Gene Therapy CDMO Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cell and Gene Therapy CDMO Services Market Competitive Situation and Trends
3.8.1 Cell and Gene Therapy CDMO Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell and Gene Therapy CDMO Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY CDMO SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Cell and Gene Therapy CDMO Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL AND GENE THERAPY CDMO SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell and Gene Therapy CDMO Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell and Gene Therapy CDMO Services Market
5.7 ESG Ratings of Leading Companies
6 CELL AND GENE THERAPY CDMO SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy CDMO Services Sales Market Share by Type (2020-2025)
6.3 Global Cell and Gene Therapy CDMO Services Market Size by Type (2020-2025)
6.4 Global Cell and Gene Therapy CDMO Services Price by Type (2020-2025)
7 CELL AND GENE THERAPY CDMO SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy CDMO Services Market Sales by Application (2020-2025)
7.3 Global Cell and Gene Therapy CDMO Services Market Size (M USD) by Application (2020-2025)
7.4 Global Cell and Gene Therapy CDMO Services Sales Growth Rate by Application (2020-2025)
8 CELL AND GENE THERAPY CDMO SERVICES MARKET SALES BY REGION
8.1 Global Cell and Gene Therapy CDMO Services Sales by Region
8.1.1 Global Cell and Gene Therapy CDMO Services Sales by Region
8.1.2 Global Cell and Gene Therapy CDMO Services Sales Market Share by Region
8.2 Global Cell and Gene Therapy CDMO Services Market Size by Region
8.2.1 Global Cell and Gene Therapy CDMO Services Market Size by Region
8.2.2 Global Cell and Gene Therapy CDMO Services Market Size by Region
8.3 North America
8.3.1 North America Cell and Gene Therapy CDMO Services Sales by Country
8.3.2 North America Cell and Gene Therapy CDMO Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell and Gene Therapy CDMO Services Sales by Country
8.4.2 Europe Cell and Gene Therapy CDMO Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell and Gene Therapy CDMO Services Sales by Region
8.5.2 Asia Pacific Cell and Gene Therapy CDMO Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell and Gene Therapy CDMO Services Sales by Country
8.6.2 South America Cell and Gene Therapy CDMO Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell and Gene Therapy CDMO Services Sales by Region
8.7.2 Middle East and Africa Cell and Gene Therapy CDMO Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL AND GENE THERAPY CDMO SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Cell and Gene Therapy CDMO Services by Region(2020-2025)
9.2 Global Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2020-2025)
9.3 Global Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell and Gene Therapy CDMO Services Production
9.4.1 North America Cell and Gene Therapy CDMO Services Production Growth Rate (2020-2025)
9.4.2 North America Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell and Gene Therapy CDMO Services Production
9.5.1 Europe Cell and Gene Therapy CDMO Services Production Growth Rate (2020-2025)
9.5.2 Europe Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell and Gene Therapy CDMO Services Production (2020-2025)
9.6.1 Japan Cell and Gene Therapy CDMO Services Production Growth Rate (2020-2025)
9.6.2 Japan Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell and Gene Therapy CDMO Services Production (2020-2025)
9.7.1 China Cell and Gene Therapy CDMO Services Production Growth Rate (2020-2025)
9.7.2 China Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Catalent
10.1.1 Catalent Basic Information
10.1.2 Catalent Cell and Gene Therapy CDMO Services Product Overview
10.1.3 Catalent Cell and Gene Therapy CDMO Services Product Market Performance
10.1.4 Catalent Business Overview
10.1.5 Catalent SWOT Analysis
10.1.6 Catalent Recent Developments
10.2 Lonza
10.2.1 Lonza Basic Information
10.2.2 Lonza Cell and Gene Therapy CDMO Services Product Overview
10.2.3 Lonza Cell and Gene Therapy CDMO Services Product Market Performance
10.2.4 Lonza Business Overview
10.2.5 Lonza SWOT Analysis
10.2.6 Lonza Recent Developments
10.3 Thermo Fisher
10.3.1 Thermo Fisher Basic Information
10.3.2 Thermo Fisher Cell and Gene Therapy CDMO Services Product Overview
10.3.3 Thermo Fisher Cell and Gene Therapy CDMO Services Product Market Performance
10.3.4 Thermo Fisher Business Overview
10.3.5 Thermo Fisher SWOT Analysis
10.3.6 Thermo Fisher Recent Developments
10.4 WuXi AppTec
10.4.1 WuXi AppTec Basic Information
10.4.2 WuXi AppTec Cell and Gene Therapy CDMO Services Product Overview
10.4.3 WuXi AppTec Cell and Gene Therapy CDMO Services Product Market Performance
10.4.4 WuXi AppTec Business Overview
10.4.5 WuXi AppTec Recent Developments
10.5 Charles River
10.5.1 Charles River Basic Information
10.5.2 Charles River Cell and Gene Therapy CDMO Services Product Overview
10.5.3 Charles River Cell and Gene Therapy CDMO Services Product Market Performance
10.5.4 Charles River Business Overview
10.5.5 Charles River Recent Developments
10.6 OxfordBioMedica
10.6.1 OxfordBioMedica Basic Information
10.6.2 OxfordBioMedica Cell and Gene Therapy CDMO Services Product Overview
10.6.3 OxfordBioMedica Cell and Gene Therapy CDMO Services Product Market Performance
10.6.4 OxfordBioMedica Business Overview
10.6.5 OxfordBioMedica Recent Developments
10.7 BrammerBio
10.7.1 BrammerBio Basic Information
10.7.2 BrammerBio Cell and Gene Therapy CDMO Services Product Overview
10.7.3 BrammerBio Cell and Gene Therapy CDMO Services Product Market Performance
10.7.4 BrammerBio Business Overview
10.7.5 BrammerBio Recent Developments
10.8 CELLfor CURE
10.8.1 CELLfor CURE Basic Information
10.8.2 CELLfor CURE Cell and Gene Therapy CDMO Services Product Overview
10.8.3 CELLfor CURE Cell and Gene Therapy CDMO Services Product Market Performance
10.8.4 CELLfor CURE Business Overview
10.8.5 CELLfor CURE Recent Developments
10.9 OBiO Technology
10.9.1 OBiO Technology Basic Information
10.9.2 OBiO Technology Cell and Gene Therapy CDMO Services Product Overview
10.9.3 OBiO Technology Cell and Gene Therapy CDMO Services Product Market Performance
10.9.4 OBiO Technology Business Overview
10.9.5 OBiO Technology Recent Developments
10.10 GenScript
10.10.1 GenScript Basic Information
10.10.2 GenScript Cell and Gene Therapy CDMO Services Product Overview
10.10.3 GenScript Cell and Gene Therapy CDMO Services Product Market Performance
10.10.4 GenScript Business Overview
10.10.5 GenScript Recent Developments
10.11 Esco
10.11.1 Esco Basic Information
10.11.2 Esco Cell and Gene Therapy CDMO Services Product Overview
10.11.3 Esco Cell and Gene Therapy CDMO Services Product Market Performance
10.11.4 Esco Business Overview
10.11.5 Esco Recent Developments
10.12 Nikon
10.12.1 Nikon Basic Information
10.12.2 Nikon Cell and Gene Therapy CDMO Services Product Overview
10.12.3 Nikon Cell and Gene Therapy CDMO Services Product Market Performance
10.12.4 Nikon Business Overview
10.12.5 Nikon Recent Developments
10.13 FUJIFILM
10.13.1 FUJIFILM Basic Information
10.13.2 FUJIFILM Cell and Gene Therapy CDMO Services Product Overview
10.13.3 FUJIFILM Cell and Gene Therapy CDMO Services Product Market Performance
10.13.4 FUJIFILM Business Overview
10.13.5 FUJIFILM Recent Developments
10.14 Pharmaron
10.14.1 Pharmaron Basic Information
10.14.2 Pharmaron Cell and Gene Therapy CDMO Services Product Overview
10.14.3 Pharmaron Cell and Gene Therapy CDMO Services Product Market Performance
10.14.4 Pharmaron Business Overview
10.14.5 Pharmaron Recent Developments
10.15 Porton
10.15.1 Porton Basic Information
10.15.2 Porton Cell and Gene Therapy CDMO Services Product Overview
10.15.3 Porton Cell and Gene Therapy CDMO Services Product Market Performance
10.15.4 Porton Business Overview
10.15.5 Porton Recent Developments
10.16 Medicilon
10.16.1 Medicilon Basic Information
10.16.2 Medicilon Cell and Gene Therapy CDMO Services Product Overview
10.16.3 Medicilon Cell and Gene Therapy CDMO Services Product Market Performance
10.16.4 Medicilon Business Overview
10.16.5 Medicilon Recent Developments
10.17 JOINN Laboratories
10.17.1 JOINN Laboratories Basic Information
10.17.2 JOINN Laboratories Cell and Gene Therapy CDMO Services Product Overview
10.17.3 JOINN Laboratories Cell and Gene Therapy CDMO Services Product Market Performance
10.17.4 JOINN Laboratories Business Overview
10.17.5 JOINN Laboratories Recent Developments
10.18 Sofpromed
10.18.1 Sofpromed Basic Information
10.18.2 Sofpromed Cell and Gene Therapy CDMO Services Product Overview
10.18.3 Sofpromed Cell and Gene Therapy CDMO Services Product Market Performance
10.18.4 Sofpromed Business Overview
10.18.5 Sofpromed Recent Developments
10.19 eXmoor
10.19.1 eXmoor Basic Information
10.19.2 eXmoor Cell and Gene Therapy CDMO Services Product Overview
10.19.3 eXmoor Cell and Gene Therapy CDMO Services Product Market Performance
10.19.4 eXmoor Business Overview
10.19.5 eXmoor Recent Developments
10.20 OmniaBio
10.20.1 OmniaBio Basic Information
10.20.2 OmniaBio Cell and Gene Therapy CDMO Services Product Overview
10.20.3 OmniaBio Cell and Gene Therapy CDMO Services Product Market Performance
10.20.4 OmniaBio Business Overview
10.20.5 OmniaBio Recent Developments
10.21 RoslinCT
10.21.1 RoslinCT Basic Information
10.21.2 RoslinCT Cell and Gene Therapy CDMO Services Product Overview
10.21.3 RoslinCT Cell and Gene Therapy CDMO Services Product Market Performance
10.21.4 RoslinCT Business Overview
10.21.5 RoslinCT Recent Developments
10.22 BioCentriq
10.22.1 BioCentriq Basic Information
10.22.2 BioCentriq Cell and Gene Therapy CDMO Services Product Overview
10.22.3 BioCentriq Cell and Gene Therapy CDMO Services Product Market Performance
10.22.4 BioCentriq Business Overview
10.22.5 BioCentriq Recent Developments
10.23 PolTREG
10.23.1 PolTREG Basic Information
10.23.2 PolTREG Cell and Gene Therapy CDMO Services Product Overview
10.23.3 PolTREG Cell and Gene Therapy CDMO Services Product Market Performance
10.23.4 PolTREG Business Overview
10.23.5 PolTREG Recent Developments
10.24 Miltenyi Bioindustry
10.24.1 Miltenyi Bioindustry Basic Information
10.24.2 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Overview
10.24.3 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Market Performance
10.24.4 Miltenyi Bioindustry Business Overview
10.24.5 Miltenyi Bioindustry Recent Developments
11 CELL AND GENE THERAPY CDMO SERVICES MARKET FORECAST BY REGION
11.1 Global Cell and Gene Therapy CDMO Services Market Size Forecast
11.2 Global Cell and Gene Therapy CDMO Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell and Gene Therapy CDMO Services Market Size Forecast by Country
11.2.3 Asia Pacific Cell and Gene Therapy CDMO Services Market Size Forecast by Region
11.2.4 South America Cell and Gene Therapy CDMO Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell and Gene Therapy CDMO Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell and Gene Therapy CDMO Services Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell and Gene Therapy CDMO Services by Type (2026-2035)
12.1.2 Global Cell and Gene Therapy CDMO Services Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell and Gene Therapy CDMO Services by Type (2026-2035)
12.2 Global Cell and Gene Therapy CDMO Services Market Forecast by Application (2026-2035)
12.2.1 Global Cell and Gene Therapy CDMO Services Sales (K Units) Forecast by Application
12.2.2 Global Cell and Gene Therapy CDMO Services Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy CDMO Services
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy CDMO Services Segment by Type
1.2.2 Cell and Gene Therapy CDMO Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL AND GENE THERAPY CDMO SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy CDMO Services Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cell and Gene Therapy CDMO Services Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL AND GENE THERAPY CDMO SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cell and Gene Therapy CDMO Services Product Life Cycle
3.3 Global Cell and Gene Therapy CDMO Services Sales by Manufacturers (2020-2025)
3.4 Global Cell and Gene Therapy CDMO Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell and Gene Therapy CDMO Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cell and Gene Therapy CDMO Services Market Competitive Situation and Trends
3.8.1 Cell and Gene Therapy CDMO Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell and Gene Therapy CDMO Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY CDMO SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Cell and Gene Therapy CDMO Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL AND GENE THERAPY CDMO SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell and Gene Therapy CDMO Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cell and Gene Therapy CDMO Services Market
5.7 ESG Ratings of Leading Companies
6 CELL AND GENE THERAPY CDMO SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy CDMO Services Sales Market Share by Type (2020-2025)
6.3 Global Cell and Gene Therapy CDMO Services Market Size by Type (2020-2025)
6.4 Global Cell and Gene Therapy CDMO Services Price by Type (2020-2025)
7 CELL AND GENE THERAPY CDMO SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy CDMO Services Market Sales by Application (2020-2025)
7.3 Global Cell and Gene Therapy CDMO Services Market Size (M USD) by Application (2020-2025)
7.4 Global Cell and Gene Therapy CDMO Services Sales Growth Rate by Application (2020-2025)
8 CELL AND GENE THERAPY CDMO SERVICES MARKET SALES BY REGION
8.1 Global Cell and Gene Therapy CDMO Services Sales by Region
8.1.1 Global Cell and Gene Therapy CDMO Services Sales by Region
8.1.2 Global Cell and Gene Therapy CDMO Services Sales Market Share by Region
8.2 Global Cell and Gene Therapy CDMO Services Market Size by Region
8.2.1 Global Cell and Gene Therapy CDMO Services Market Size by Region
8.2.2 Global Cell and Gene Therapy CDMO Services Market Size by Region
8.3 North America
8.3.1 North America Cell and Gene Therapy CDMO Services Sales by Country
8.3.2 North America Cell and Gene Therapy CDMO Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cell and Gene Therapy CDMO Services Sales by Country
8.4.2 Europe Cell and Gene Therapy CDMO Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cell and Gene Therapy CDMO Services Sales by Region
8.5.2 Asia Pacific Cell and Gene Therapy CDMO Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cell and Gene Therapy CDMO Services Sales by Country
8.6.2 South America Cell and Gene Therapy CDMO Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cell and Gene Therapy CDMO Services Sales by Region
8.7.2 Middle East and Africa Cell and Gene Therapy CDMO Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CELL AND GENE THERAPY CDMO SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Cell and Gene Therapy CDMO Services by Region(2020-2025)
9.2 Global Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2020-2025)
9.3 Global Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cell and Gene Therapy CDMO Services Production
9.4.1 North America Cell and Gene Therapy CDMO Services Production Growth Rate (2020-2025)
9.4.2 North America Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cell and Gene Therapy CDMO Services Production
9.5.1 Europe Cell and Gene Therapy CDMO Services Production Growth Rate (2020-2025)
9.5.2 Europe Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cell and Gene Therapy CDMO Services Production (2020-2025)
9.6.1 Japan Cell and Gene Therapy CDMO Services Production Growth Rate (2020-2025)
9.6.2 Japan Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cell and Gene Therapy CDMO Services Production (2020-2025)
9.7.1 China Cell and Gene Therapy CDMO Services Production Growth Rate (2020-2025)
9.7.2 China Cell and Gene Therapy CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Catalent
10.1.1 Catalent Basic Information
10.1.2 Catalent Cell and Gene Therapy CDMO Services Product Overview
10.1.3 Catalent Cell and Gene Therapy CDMO Services Product Market Performance
10.1.4 Catalent Business Overview
10.1.5 Catalent SWOT Analysis
10.1.6 Catalent Recent Developments
10.2 Lonza
10.2.1 Lonza Basic Information
10.2.2 Lonza Cell and Gene Therapy CDMO Services Product Overview
10.2.3 Lonza Cell and Gene Therapy CDMO Services Product Market Performance
10.2.4 Lonza Business Overview
10.2.5 Lonza SWOT Analysis
10.2.6 Lonza Recent Developments
10.3 Thermo Fisher
10.3.1 Thermo Fisher Basic Information
10.3.2 Thermo Fisher Cell and Gene Therapy CDMO Services Product Overview
10.3.3 Thermo Fisher Cell and Gene Therapy CDMO Services Product Market Performance
10.3.4 Thermo Fisher Business Overview
10.3.5 Thermo Fisher SWOT Analysis
10.3.6 Thermo Fisher Recent Developments
10.4 WuXi AppTec
10.4.1 WuXi AppTec Basic Information
10.4.2 WuXi AppTec Cell and Gene Therapy CDMO Services Product Overview
10.4.3 WuXi AppTec Cell and Gene Therapy CDMO Services Product Market Performance
10.4.4 WuXi AppTec Business Overview
10.4.5 WuXi AppTec Recent Developments
10.5 Charles River
10.5.1 Charles River Basic Information
10.5.2 Charles River Cell and Gene Therapy CDMO Services Product Overview
10.5.3 Charles River Cell and Gene Therapy CDMO Services Product Market Performance
10.5.4 Charles River Business Overview
10.5.5 Charles River Recent Developments
10.6 OxfordBioMedica
10.6.1 OxfordBioMedica Basic Information
10.6.2 OxfordBioMedica Cell and Gene Therapy CDMO Services Product Overview
10.6.3 OxfordBioMedica Cell and Gene Therapy CDMO Services Product Market Performance
10.6.4 OxfordBioMedica Business Overview
10.6.5 OxfordBioMedica Recent Developments
10.7 BrammerBio
10.7.1 BrammerBio Basic Information
10.7.2 BrammerBio Cell and Gene Therapy CDMO Services Product Overview
10.7.3 BrammerBio Cell and Gene Therapy CDMO Services Product Market Performance
10.7.4 BrammerBio Business Overview
10.7.5 BrammerBio Recent Developments
10.8 CELLfor CURE
10.8.1 CELLfor CURE Basic Information
10.8.2 CELLfor CURE Cell and Gene Therapy CDMO Services Product Overview
10.8.3 CELLfor CURE Cell and Gene Therapy CDMO Services Product Market Performance
10.8.4 CELLfor CURE Business Overview
10.8.5 CELLfor CURE Recent Developments
10.9 OBiO Technology
10.9.1 OBiO Technology Basic Information
10.9.2 OBiO Technology Cell and Gene Therapy CDMO Services Product Overview
10.9.3 OBiO Technology Cell and Gene Therapy CDMO Services Product Market Performance
10.9.4 OBiO Technology Business Overview
10.9.5 OBiO Technology Recent Developments
10.10 GenScript
10.10.1 GenScript Basic Information
10.10.2 GenScript Cell and Gene Therapy CDMO Services Product Overview
10.10.3 GenScript Cell and Gene Therapy CDMO Services Product Market Performance
10.10.4 GenScript Business Overview
10.10.5 GenScript Recent Developments
10.11 Esco
10.11.1 Esco Basic Information
10.11.2 Esco Cell and Gene Therapy CDMO Services Product Overview
10.11.3 Esco Cell and Gene Therapy CDMO Services Product Market Performance
10.11.4 Esco Business Overview
10.11.5 Esco Recent Developments
10.12 Nikon
10.12.1 Nikon Basic Information
10.12.2 Nikon Cell and Gene Therapy CDMO Services Product Overview
10.12.3 Nikon Cell and Gene Therapy CDMO Services Product Market Performance
10.12.4 Nikon Business Overview
10.12.5 Nikon Recent Developments
10.13 FUJIFILM
10.13.1 FUJIFILM Basic Information
10.13.2 FUJIFILM Cell and Gene Therapy CDMO Services Product Overview
10.13.3 FUJIFILM Cell and Gene Therapy CDMO Services Product Market Performance
10.13.4 FUJIFILM Business Overview
10.13.5 FUJIFILM Recent Developments
10.14 Pharmaron
10.14.1 Pharmaron Basic Information
10.14.2 Pharmaron Cell and Gene Therapy CDMO Services Product Overview
10.14.3 Pharmaron Cell and Gene Therapy CDMO Services Product Market Performance
10.14.4 Pharmaron Business Overview
10.14.5 Pharmaron Recent Developments
10.15 Porton
10.15.1 Porton Basic Information
10.15.2 Porton Cell and Gene Therapy CDMO Services Product Overview
10.15.3 Porton Cell and Gene Therapy CDMO Services Product Market Performance
10.15.4 Porton Business Overview
10.15.5 Porton Recent Developments
10.16 Medicilon
10.16.1 Medicilon Basic Information
10.16.2 Medicilon Cell and Gene Therapy CDMO Services Product Overview
10.16.3 Medicilon Cell and Gene Therapy CDMO Services Product Market Performance
10.16.4 Medicilon Business Overview
10.16.5 Medicilon Recent Developments
10.17 JOINN Laboratories
10.17.1 JOINN Laboratories Basic Information
10.17.2 JOINN Laboratories Cell and Gene Therapy CDMO Services Product Overview
10.17.3 JOINN Laboratories Cell and Gene Therapy CDMO Services Product Market Performance
10.17.4 JOINN Laboratories Business Overview
10.17.5 JOINN Laboratories Recent Developments
10.18 Sofpromed
10.18.1 Sofpromed Basic Information
10.18.2 Sofpromed Cell and Gene Therapy CDMO Services Product Overview
10.18.3 Sofpromed Cell and Gene Therapy CDMO Services Product Market Performance
10.18.4 Sofpromed Business Overview
10.18.5 Sofpromed Recent Developments
10.19 eXmoor
10.19.1 eXmoor Basic Information
10.19.2 eXmoor Cell and Gene Therapy CDMO Services Product Overview
10.19.3 eXmoor Cell and Gene Therapy CDMO Services Product Market Performance
10.19.4 eXmoor Business Overview
10.19.5 eXmoor Recent Developments
10.20 OmniaBio
10.20.1 OmniaBio Basic Information
10.20.2 OmniaBio Cell and Gene Therapy CDMO Services Product Overview
10.20.3 OmniaBio Cell and Gene Therapy CDMO Services Product Market Performance
10.20.4 OmniaBio Business Overview
10.20.5 OmniaBio Recent Developments
10.21 RoslinCT
10.21.1 RoslinCT Basic Information
10.21.2 RoslinCT Cell and Gene Therapy CDMO Services Product Overview
10.21.3 RoslinCT Cell and Gene Therapy CDMO Services Product Market Performance
10.21.4 RoslinCT Business Overview
10.21.5 RoslinCT Recent Developments
10.22 BioCentriq
10.22.1 BioCentriq Basic Information
10.22.2 BioCentriq Cell and Gene Therapy CDMO Services Product Overview
10.22.3 BioCentriq Cell and Gene Therapy CDMO Services Product Market Performance
10.22.4 BioCentriq Business Overview
10.22.5 BioCentriq Recent Developments
10.23 PolTREG
10.23.1 PolTREG Basic Information
10.23.2 PolTREG Cell and Gene Therapy CDMO Services Product Overview
10.23.3 PolTREG Cell and Gene Therapy CDMO Services Product Market Performance
10.23.4 PolTREG Business Overview
10.23.5 PolTREG Recent Developments
10.24 Miltenyi Bioindustry
10.24.1 Miltenyi Bioindustry Basic Information
10.24.2 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Overview
10.24.3 Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Market Performance
10.24.4 Miltenyi Bioindustry Business Overview
10.24.5 Miltenyi Bioindustry Recent Developments
11 CELL AND GENE THERAPY CDMO SERVICES MARKET FORECAST BY REGION
11.1 Global Cell and Gene Therapy CDMO Services Market Size Forecast
11.2 Global Cell and Gene Therapy CDMO Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cell and Gene Therapy CDMO Services Market Size Forecast by Country
11.2.3 Asia Pacific Cell and Gene Therapy CDMO Services Market Size Forecast by Region
11.2.4 South America Cell and Gene Therapy CDMO Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cell and Gene Therapy CDMO Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cell and Gene Therapy CDMO Services Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cell and Gene Therapy CDMO Services by Type (2026-2035)
12.1.2 Global Cell and Gene Therapy CDMO Services Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cell and Gene Therapy CDMO Services by Type (2026-2035)
12.2 Global Cell and Gene Therapy CDMO Services Market Forecast by Application (2026-2035)
12.2.1 Global Cell and Gene Therapy CDMO Services Sales (K Units) Forecast by Application
12.2.2 Global Cell and Gene Therapy CDMO Services Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell and Gene Therapy CDMO Services Market Size by Type (M USD)
Table 4. Global Cell and Gene Therapy CDMO Services Market Size by Application
Table 5. Cell and Gene Therapy CDMO Services Market Size Comparison by Region (M USD)
Table 6. Global Cell and Gene Therapy CDMO Services Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell and Gene Therapy CDMO Services Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell and Gene Therapy CDMO Services Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell and Gene Therapy CDMO Services Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2025)
Table 11. Global Market Cell and Gene Therapy CDMO Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cell and Gene Therapy CDMO Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy CDMO Services Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell and Gene Therapy CDMO Services Sales by Type (K Units)
Table 27. Global Cell and Gene Therapy CDMO Services Market Size by Type (M USD)
Table 28. Global Cell and Gene Therapy CDMO Services Sales (K Units) by Type (2020-2025)
Table 29. Global Cell and Gene Therapy CDMO Services Sales Market Share by Type (2020-2025)
Table 30. Global Cell and Gene Therapy CDMO Services Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell and Gene Therapy CDMO Services Market Share by Type (2020-2025)
Table 32. Global Cell and Gene Therapy CDMO Services Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell and Gene Therapy CDMO Services Sales (K Units) by Application
Table 34. Global Cell and Gene Therapy CDMO Services Market Size by Application
Table 35. Global Cell and Gene Therapy CDMO Services Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell and Gene Therapy CDMO Services Sales Market Share by Application (2020-2025)
Table 37. Global Cell and Gene Therapy CDMO Services Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell and Gene Therapy CDMO Services Market Share by Application (2020-2025)
Table 39. Global Cell and Gene Therapy CDMO Services Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell and Gene Therapy CDMO Services Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell and Gene Therapy CDMO Services Sales Market Share by Region (2020-2025)
Table 42. Global Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025)
Table 44. North America Cell and Gene Therapy CDMO Services Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell and Gene Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell and Gene Therapy CDMO Services Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell and Gene Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell and Gene Therapy CDMO Services Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell and Gene Therapy CDMO Services Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell and Gene Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell and Gene Therapy CDMO Services Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell and Gene Therapy CDMO Services Production (K Units) by Region(2020-2025)
Table 55. Global Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2020-2025)
Table 57. Global Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Catalent Basic Information
Table 63. Catalent Cell and Gene Therapy CDMO Services Product Overview
Table 64. Catalent Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Catalent Business Overview
Table 66. Catalent SWOT Analysis
Table 67. Catalent Recent Developments
Table 68. Lonza Basic Information
Table 69. Lonza Cell and Gene Therapy CDMO Services Product Overview
Table 70. Lonza Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Lonza Business Overview
Table 72. Lonza SWOT Analysis
Table 73. Lonza Recent Developments
Table 74. Thermo Fisher Basic Information
Table 75. Thermo Fisher Cell and Gene Therapy CDMO Services Product Overview
Table 76. Thermo Fisher Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Thermo Fisher Business Overview
Table 78. Thermo Fisher SWOT Analysis
Table 79. Thermo Fisher Recent Developments
Table 80. WuXi AppTec Basic Information
Table 81. WuXi AppTec Cell and Gene Therapy CDMO Services Product Overview
Table 82. WuXi AppTec Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. WuXi AppTec Business Overview
Table 84. WuXi AppTec Recent Developments
Table 85. Charles River Basic Information
Table 86. Charles River Cell and Gene Therapy CDMO Services Product Overview
Table 87. Charles River Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Charles River Business Overview
Table 89. Charles River Recent Developments
Table 90. OxfordBioMedica Basic Information
Table 91. OxfordBioMedica Cell and Gene Therapy CDMO Services Product Overview
Table 92. OxfordBioMedica Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. OxfordBioMedica Business Overview
Table 94. OxfordBioMedica Recent Developments
Table 95. BrammerBio Basic Information
Table 96. BrammerBio Cell and Gene Therapy CDMO Services Product Overview
Table 97. BrammerBio Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. BrammerBio Business Overview
Table 99. BrammerBio Recent Developments
Table 100. CELLfor CURE Basic Information
Table 101. CELLfor CURE Cell and Gene Therapy CDMO Services Product Overview
Table 102. CELLfor CURE Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. CELLfor CURE Business Overview
Table 104. CELLfor CURE Recent Developments
Table 105. OBiO Technology Basic Information
Table 106. OBiO Technology Cell and Gene Therapy CDMO Services Product Overview
Table 107. OBiO Technology Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. OBiO Technology Business Overview
Table 109. OBiO Technology Recent Developments
Table 110. GenScript Basic Information
Table 111. GenScript Cell and Gene Therapy CDMO Services Product Overview
Table 112. GenScript Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. GenScript Business Overview
Table 114. GenScript Recent Developments
Table 115. Esco Basic Information
Table 116. Esco Cell and Gene Therapy CDMO Services Product Overview
Table 117. Esco Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Esco Business Overview
Table 119. Esco Recent Developments
Table 120. Nikon Basic Information
Table 121. Nikon Cell and Gene Therapy CDMO Services Product Overview
Table 122. Nikon Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Nikon Business Overview
Table 124. Nikon Recent Developments
Table 125. FUJIFILM Basic Information
Table 126. FUJIFILM Cell and Gene Therapy CDMO Services Product Overview
Table 127. FUJIFILM Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. FUJIFILM Business Overview
Table 129. FUJIFILM Recent Developments
Table 130. Pharmaron Basic Information
Table 131. Pharmaron Cell and Gene Therapy CDMO Services Product Overview
Table 132. Pharmaron Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Pharmaron Business Overview
Table 134. Pharmaron Recent Developments
Table 135. Porton Basic Information
Table 136. Porton Cell and Gene Therapy CDMO Services Product Overview
Table 137. Porton Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Porton Business Overview
Table 139. Porton Recent Developments
Table 140. Medicilon Basic Information
Table 141. Medicilon Cell and Gene Therapy CDMO Services Product Overview
Table 142. Medicilon Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Medicilon Business Overview
Table 144. Medicilon Recent Developments
Table 145. JOINN Laboratories Basic Information
Table 146. JOINN Laboratories Cell and Gene Therapy CDMO Services Product Overview
Table 147. JOINN Laboratories Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. JOINN Laboratories Business Overview
Table 149. JOINN Laboratories Recent Developments
Table 150. Sofpromed Basic Information
Table 151. Sofpromed Cell and Gene Therapy CDMO Services Product Overview
Table 152. Sofpromed Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Sofpromed Business Overview
Table 154. Sofpromed Recent Developments
Table 155. eXmoor Basic Information
Table 156. eXmoor Cell and Gene Therapy CDMO Services Product Overview
Table 157. eXmoor Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. eXmoor Business Overview
Table 159. eXmoor Recent Developments
Table 160. OmniaBio Basic Information
Table 161. OmniaBio Cell and Gene Therapy CDMO Services Product Overview
Table 162. OmniaBio Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. OmniaBio Business Overview
Table 164. OmniaBio Recent Developments
Table 165. RoslinCT Basic Information
Table 166. RoslinCT Cell and Gene Therapy CDMO Services Product Overview
Table 167. RoslinCT Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. RoslinCT Business Overview
Table 169. RoslinCT Recent Developments
Table 170. BioCentriq Basic Information
Table 171. BioCentriq Cell and Gene Therapy CDMO Services Product Overview
Table 172. BioCentriq Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. BioCentriq Business Overview
Table 174. BioCentriq Recent Developments
Table 175. PolTREG Basic Information
Table 176. PolTREG Cell and Gene Therapy CDMO Services Product Overview
Table 177. PolTREG Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. PolTREG Business Overview
Table 179. PolTREG Recent Developments
Table 180. Miltenyi Bioindustry Basic Information
Table 181. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Overview
Table 182. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Miltenyi Bioindustry Business Overview
Table 184. Miltenyi Bioindustry Recent Developments
Table 185. Global Cell and Gene Therapy CDMO Services Sales Forecast by Region (2026-2035) & (K Units)
Table 186. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 187. North America Cell and Gene Therapy CDMO Services Sales Forecast by Country (2026-2035) & (K Units)
Table 188. North America Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 189. Europe Cell and Gene Therapy CDMO Services Sales Forecast by Country (2026-2035) & (K Units)
Table 190. Europe Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 191. Asia Pacific Cell and Gene Therapy CDMO Services Sales Forecast by Region (2026-2035) & (K Units)
Table 192. Asia Pacific Cell and Gene Therapy CDMO Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 193. South America Cell and Gene Therapy CDMO Services Sales Forecast by Country (2026-2035) & (K Units)
Table 194. South America Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 195. Middle East and Africa Cell and Gene Therapy CDMO Services Sales Forecast by Country (2026-2035) & (Units)
Table 196. Middle East and Africa Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 197. Global Cell and Gene Therapy CDMO Services Sales Forecast by Type (2026-2035) & (K Units)
Table 198. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 199. Global Cell and Gene Therapy CDMO Services Price Forecast by Type (2026-2035) & (USD/Unit)
Table 200. Global Cell and Gene Therapy CDMO Services Sales (K Units) Forecast by Application (2026-2035)
Table 201. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cell and Gene Therapy CDMO Services Market Size by Type (M USD)
Table 4. Global Cell and Gene Therapy CDMO Services Market Size by Application
Table 5. Cell and Gene Therapy CDMO Services Market Size Comparison by Region (M USD)
Table 6. Global Cell and Gene Therapy CDMO Services Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cell and Gene Therapy CDMO Services Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cell and Gene Therapy CDMO Services Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cell and Gene Therapy CDMO Services Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy CDMO Services as of 2025)
Table 11. Global Market Cell and Gene Therapy CDMO Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cell and Gene Therapy CDMO Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy CDMO Services Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cell and Gene Therapy CDMO Services Sales by Type (K Units)
Table 27. Global Cell and Gene Therapy CDMO Services Market Size by Type (M USD)
Table 28. Global Cell and Gene Therapy CDMO Services Sales (K Units) by Type (2020-2025)
Table 29. Global Cell and Gene Therapy CDMO Services Sales Market Share by Type (2020-2025)
Table 30. Global Cell and Gene Therapy CDMO Services Market Size (M USD) by Type (2020-2025)
Table 31. Global Cell and Gene Therapy CDMO Services Market Share by Type (2020-2025)
Table 32. Global Cell and Gene Therapy CDMO Services Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cell and Gene Therapy CDMO Services Sales (K Units) by Application
Table 34. Global Cell and Gene Therapy CDMO Services Market Size by Application
Table 35. Global Cell and Gene Therapy CDMO Services Sales by Application (2020-2025) & (K Units)
Table 36. Global Cell and Gene Therapy CDMO Services Sales Market Share by Application (2020-2025)
Table 37. Global Cell and Gene Therapy CDMO Services Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cell and Gene Therapy CDMO Services Market Share by Application (2020-2025)
Table 39. Global Cell and Gene Therapy CDMO Services Sales Growth Rate by Application (2020-2025)
Table 40. Global Cell and Gene Therapy CDMO Services Sales by Region (2020-2025) & (K Units)
Table 41. Global Cell and Gene Therapy CDMO Services Sales Market Share by Region (2020-2025)
Table 42. Global Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025)
Table 44. North America Cell and Gene Therapy CDMO Services Sales by Country (2020-2025) & (K Units)
Table 45. North America Cell and Gene Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cell and Gene Therapy CDMO Services Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cell and Gene Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cell and Gene Therapy CDMO Services Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cell and Gene Therapy CDMO Services Sales by Country (2020-2025) & (K Units)
Table 51. South America Cell and Gene Therapy CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cell and Gene Therapy CDMO Services Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cell and Gene Therapy CDMO Services Production (K Units) by Region(2020-2025)
Table 55. Global Cell and Gene Therapy CDMO Services Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cell and Gene Therapy CDMO Services Revenue Market Share by Region (2020-2025)
Table 57. Global Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cell and Gene Therapy CDMO Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Catalent Basic Information
Table 63. Catalent Cell and Gene Therapy CDMO Services Product Overview
Table 64. Catalent Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Catalent Business Overview
Table 66. Catalent SWOT Analysis
Table 67. Catalent Recent Developments
Table 68. Lonza Basic Information
Table 69. Lonza Cell and Gene Therapy CDMO Services Product Overview
Table 70. Lonza Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Lonza Business Overview
Table 72. Lonza SWOT Analysis
Table 73. Lonza Recent Developments
Table 74. Thermo Fisher Basic Information
Table 75. Thermo Fisher Cell and Gene Therapy CDMO Services Product Overview
Table 76. Thermo Fisher Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Thermo Fisher Business Overview
Table 78. Thermo Fisher SWOT Analysis
Table 79. Thermo Fisher Recent Developments
Table 80. WuXi AppTec Basic Information
Table 81. WuXi AppTec Cell and Gene Therapy CDMO Services Product Overview
Table 82. WuXi AppTec Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. WuXi AppTec Business Overview
Table 84. WuXi AppTec Recent Developments
Table 85. Charles River Basic Information
Table 86. Charles River Cell and Gene Therapy CDMO Services Product Overview
Table 87. Charles River Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Charles River Business Overview
Table 89. Charles River Recent Developments
Table 90. OxfordBioMedica Basic Information
Table 91. OxfordBioMedica Cell and Gene Therapy CDMO Services Product Overview
Table 92. OxfordBioMedica Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. OxfordBioMedica Business Overview
Table 94. OxfordBioMedica Recent Developments
Table 95. BrammerBio Basic Information
Table 96. BrammerBio Cell and Gene Therapy CDMO Services Product Overview
Table 97. BrammerBio Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. BrammerBio Business Overview
Table 99. BrammerBio Recent Developments
Table 100. CELLfor CURE Basic Information
Table 101. CELLfor CURE Cell and Gene Therapy CDMO Services Product Overview
Table 102. CELLfor CURE Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. CELLfor CURE Business Overview
Table 104. CELLfor CURE Recent Developments
Table 105. OBiO Technology Basic Information
Table 106. OBiO Technology Cell and Gene Therapy CDMO Services Product Overview
Table 107. OBiO Technology Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. OBiO Technology Business Overview
Table 109. OBiO Technology Recent Developments
Table 110. GenScript Basic Information
Table 111. GenScript Cell and Gene Therapy CDMO Services Product Overview
Table 112. GenScript Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. GenScript Business Overview
Table 114. GenScript Recent Developments
Table 115. Esco Basic Information
Table 116. Esco Cell and Gene Therapy CDMO Services Product Overview
Table 117. Esco Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Esco Business Overview
Table 119. Esco Recent Developments
Table 120. Nikon Basic Information
Table 121. Nikon Cell and Gene Therapy CDMO Services Product Overview
Table 122. Nikon Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Nikon Business Overview
Table 124. Nikon Recent Developments
Table 125. FUJIFILM Basic Information
Table 126. FUJIFILM Cell and Gene Therapy CDMO Services Product Overview
Table 127. FUJIFILM Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. FUJIFILM Business Overview
Table 129. FUJIFILM Recent Developments
Table 130. Pharmaron Basic Information
Table 131. Pharmaron Cell and Gene Therapy CDMO Services Product Overview
Table 132. Pharmaron Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Pharmaron Business Overview
Table 134. Pharmaron Recent Developments
Table 135. Porton Basic Information
Table 136. Porton Cell and Gene Therapy CDMO Services Product Overview
Table 137. Porton Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Porton Business Overview
Table 139. Porton Recent Developments
Table 140. Medicilon Basic Information
Table 141. Medicilon Cell and Gene Therapy CDMO Services Product Overview
Table 142. Medicilon Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Medicilon Business Overview
Table 144. Medicilon Recent Developments
Table 145. JOINN Laboratories Basic Information
Table 146. JOINN Laboratories Cell and Gene Therapy CDMO Services Product Overview
Table 147. JOINN Laboratories Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. JOINN Laboratories Business Overview
Table 149. JOINN Laboratories Recent Developments
Table 150. Sofpromed Basic Information
Table 151. Sofpromed Cell and Gene Therapy CDMO Services Product Overview
Table 152. Sofpromed Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Sofpromed Business Overview
Table 154. Sofpromed Recent Developments
Table 155. eXmoor Basic Information
Table 156. eXmoor Cell and Gene Therapy CDMO Services Product Overview
Table 157. eXmoor Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. eXmoor Business Overview
Table 159. eXmoor Recent Developments
Table 160. OmniaBio Basic Information
Table 161. OmniaBio Cell and Gene Therapy CDMO Services Product Overview
Table 162. OmniaBio Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. OmniaBio Business Overview
Table 164. OmniaBio Recent Developments
Table 165. RoslinCT Basic Information
Table 166. RoslinCT Cell and Gene Therapy CDMO Services Product Overview
Table 167. RoslinCT Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. RoslinCT Business Overview
Table 169. RoslinCT Recent Developments
Table 170. BioCentriq Basic Information
Table 171. BioCentriq Cell and Gene Therapy CDMO Services Product Overview
Table 172. BioCentriq Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. BioCentriq Business Overview
Table 174. BioCentriq Recent Developments
Table 175. PolTREG Basic Information
Table 176. PolTREG Cell and Gene Therapy CDMO Services Product Overview
Table 177. PolTREG Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. PolTREG Business Overview
Table 179. PolTREG Recent Developments
Table 180. Miltenyi Bioindustry Basic Information
Table 181. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Product Overview
Table 182. Miltenyi Bioindustry Cell and Gene Therapy CDMO Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Miltenyi Bioindustry Business Overview
Table 184. Miltenyi Bioindustry Recent Developments
Table 185. Global Cell and Gene Therapy CDMO Services Sales Forecast by Region (2026-2035) & (K Units)
Table 186. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 187. North America Cell and Gene Therapy CDMO Services Sales Forecast by Country (2026-2035) & (K Units)
Table 188. North America Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 189. Europe Cell and Gene Therapy CDMO Services Sales Forecast by Country (2026-2035) & (K Units)
Table 190. Europe Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 191. Asia Pacific Cell and Gene Therapy CDMO Services Sales Forecast by Region (2026-2035) & (K Units)
Table 192. Asia Pacific Cell and Gene Therapy CDMO Services Market Size Forecast by Region (2026-2035) & (M USD)
Table 193. South America Cell and Gene Therapy CDMO Services Sales Forecast by Country (2026-2035) & (K Units)
Table 194. South America Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 195. Middle East and Africa Cell and Gene Therapy CDMO Services Sales Forecast by Country (2026-2035) & (Units)
Table 196. Middle East and Africa Cell and Gene Therapy CDMO Services Market Size Forecast by Country (2026-2035) & (M USD)
Table 197. Global Cell and Gene Therapy CDMO Services Sales Forecast by Type (2026-2035) & (K Units)
Table 198. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Type (2026-2035) & (M USD)
Table 199. Global Cell and Gene Therapy CDMO Services Price Forecast by Type (2026-2035) & (USD/Unit)
Table 200. Global Cell and Gene Therapy CDMO Services Sales (K Units) Forecast by Application (2026-2035)
Table 201. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cell and Gene Therapy CDMO Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy CDMO Services Market Size (M USD), 2025-2035
Figure 5. Global Cell and Gene Therapy CDMO Services Market Size (M USD) (2020-2035)
Figure 6. Global Cell and Gene Therapy CDMO Services Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy CDMO Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell and Gene Therapy CDMO Services Product Life Cycle
Figure 13. Cell and Gene Therapy CDMO Services Sales Share by Manufacturers in 2025
Figure 14. Global Cell and Gene Therapy CDMO Services Revenue Share by Manufacturers in 2025
Figure 15. Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell and Gene Therapy CDMO Services Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy CDMO Services Revenue in 2025
Figure 18. Industry Chain Map of Cell and Gene Therapy CDMO Services
Figure 19. Global Cell and Gene Therapy CDMO Services Market PEST Analysis
Figure 20. Global Cell and Gene Therapy CDMO Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell and Gene Therapy CDMO Services Market Share by Type
Figure 27. Sales Market Share of Cell and Gene Therapy CDMO Services by Type (2020-2025)
Figure 28. Sales Market Share of Cell and Gene Therapy CDMO Services by Type in 2025
Figure 29. Market Share of Cell and Gene Therapy CDMO Services by Type (2020-2025)
Figure 30. Market Share of Cell and Gene Therapy CDMO Services by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell and Gene Therapy CDMO Services Market Share by Application
Figure 33. Global Cell and Gene Therapy CDMO Services Sales Market Share by Application (2020-2025)
Figure 34. Global Cell and Gene Therapy CDMO Services Sales Market Share by Application in 2025
Figure 35. Global Cell and Gene Therapy CDMO Services Market Share by Application (2020-2025)
Figure 36. Global Cell and Gene Therapy CDMO Services Market Share by Application in 2025
Figure 37. Global Cell and Gene Therapy CDMO Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell and Gene Therapy CDMO Services Sales Market Share by Region (2020-2025)
Figure 39. Global Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025)
Figure 40. North America Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell and Gene Therapy CDMO Services Sales Market Share by Country in 2024
Figure 43. North America Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell and Gene Therapy CDMO Services Market Size by Country in 2024
Figure 45. U.S. Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell and Gene Therapy CDMO Services Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell and Gene Therapy CDMO Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell and Gene Therapy CDMO Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell and Gene Therapy CDMO Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell and Gene Therapy CDMO Services Sales Market Share by Country in 2024
Figure 53. Europe Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell and Gene Therapy CDMO Services Market Size by Country in 2024
Figure 55. Germany Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell and Gene Therapy CDMO Services Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell and Gene Therapy CDMO Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell and Gene Therapy CDMO Services Market Size by Region in 2024
Figure 68. China Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell and Gene Therapy CDMO Services Sales and Growth Rate (K Units)
Figure 79. South America Cell and Gene Therapy CDMO Services Sales Market Share by Country in 2024
Figure 80. South America Cell and Gene Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 81. South America Cell and Gene Therapy CDMO Services Market Size by Country in 2024
Figure 82. Brazil Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell and Gene Therapy CDMO Services Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell and Gene Therapy CDMO Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell and Gene Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell and Gene Therapy CDMO Services Market Size by Region in 2024
Figure 92. Saudi Arabia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell and Gene Therapy CDMO Services Production Market Share by Region (2020-2025)
Figure 103. North America Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell and Gene Therapy CDMO Services Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell and Gene Therapy CDMO Services Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell and Gene Therapy CDMO Services Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell and Gene Therapy CDMO Services Sales Forecast by Application (2026-2035)
Figure 112. Global Cell and Gene Therapy CDMO Services Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Cell and Gene Therapy CDMO Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy CDMO Services Market Size (M USD), 2025-2035
Figure 5. Global Cell and Gene Therapy CDMO Services Market Size (M USD) (2020-2035)
Figure 6. Global Cell and Gene Therapy CDMO Services Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy CDMO Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell and Gene Therapy CDMO Services Product Life Cycle
Figure 13. Cell and Gene Therapy CDMO Services Sales Share by Manufacturers in 2025
Figure 14. Global Cell and Gene Therapy CDMO Services Revenue Share by Manufacturers in 2025
Figure 15. Cell and Gene Therapy CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cell and Gene Therapy CDMO Services Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy CDMO Services Revenue in 2025
Figure 18. Industry Chain Map of Cell and Gene Therapy CDMO Services
Figure 19. Global Cell and Gene Therapy CDMO Services Market PEST Analysis
Figure 20. Global Cell and Gene Therapy CDMO Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cell and Gene Therapy CDMO Services Market Share by Type
Figure 27. Sales Market Share of Cell and Gene Therapy CDMO Services by Type (2020-2025)
Figure 28. Sales Market Share of Cell and Gene Therapy CDMO Services by Type in 2025
Figure 29. Market Share of Cell and Gene Therapy CDMO Services by Type (2020-2025)
Figure 30. Market Share of Cell and Gene Therapy CDMO Services by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cell and Gene Therapy CDMO Services Market Share by Application
Figure 33. Global Cell and Gene Therapy CDMO Services Sales Market Share by Application (2020-2025)
Figure 34. Global Cell and Gene Therapy CDMO Services Sales Market Share by Application in 2025
Figure 35. Global Cell and Gene Therapy CDMO Services Market Share by Application (2020-2025)
Figure 36. Global Cell and Gene Therapy CDMO Services Market Share by Application in 2025
Figure 37. Global Cell and Gene Therapy CDMO Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cell and Gene Therapy CDMO Services Sales Market Share by Region (2020-2025)
Figure 39. Global Cell and Gene Therapy CDMO Services Market Size by Region (2020-2025)
Figure 40. North America Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cell and Gene Therapy CDMO Services Sales Market Share by Country in 2024
Figure 43. North America Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cell and Gene Therapy CDMO Services Market Size by Country in 2024
Figure 45. U.S. Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cell and Gene Therapy CDMO Services Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cell and Gene Therapy CDMO Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cell and Gene Therapy CDMO Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cell and Gene Therapy CDMO Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cell and Gene Therapy CDMO Services Sales Market Share by Country in 2024
Figure 53. Europe Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cell and Gene Therapy CDMO Services Market Size by Country in 2024
Figure 55. Germany Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cell and Gene Therapy CDMO Services Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cell and Gene Therapy CDMO Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cell and Gene Therapy CDMO Services Market Size by Region in 2024
Figure 68. China Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cell and Gene Therapy CDMO Services Sales and Growth Rate (K Units)
Figure 79. South America Cell and Gene Therapy CDMO Services Sales Market Share by Country in 2024
Figure 80. South America Cell and Gene Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 81. South America Cell and Gene Therapy CDMO Services Market Size by Country in 2024
Figure 82. Brazil Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cell and Gene Therapy CDMO Services Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cell and Gene Therapy CDMO Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cell and Gene Therapy CDMO Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cell and Gene Therapy CDMO Services Market Size by Region in 2024
Figure 92. Saudi Arabia Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cell and Gene Therapy CDMO Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cell and Gene Therapy CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cell and Gene Therapy CDMO Services Production Market Share by Region (2020-2025)
Figure 103. North America Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cell and Gene Therapy CDMO Services Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cell and Gene Therapy CDMO Services Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cell and Gene Therapy CDMO Services Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cell and Gene Therapy CDMO Services Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cell and Gene Therapy CDMO Services Market Share Forecast by Type (2026-2035)
Figure 111. Global Cell and Gene Therapy CDMO Services Sales Forecast by Application (2026-2035)
Figure 112. Global Cell and Gene Therapy CDMO Services Market Share Forecast by Application (2026-2035)
